Wilford Hall Medical Center HIV Publications

  1. O'Connell, R.J., T.M. Merritt, J.A. Malia, T.C. VanCott, M.J. Dolan, H. Zahwa, W.P. Bradley, B.M. Branson, N.L. Michael, and C.C. De Witt,Performance of the OraQuick rapid antibody test for diagnosis of human immunodeficiency virus type 1 infection in patients with various levels of exposure to highly active antiretroviral therapy. Journal of Clinical Microbiology., 2003. 41(5): p. 2153-5.
  2. Lin, A.L., D.A. Johnson, K.T. Stephan, and C.K. Yeh, Alteration in salivary function in early HIV infection. Journal of Dental Research., 2003. 82(9): p. 719-24.
  3. Crum, N.F., M.R. Wallace, K. Stephan, D.L. Blazes, N. Aronson, S.A. Tasker, A.G. Thomas, S. Wegner, C. Casper, A. Wald, L. Corey, and S.K. Brodine, Correlates of human herpesvirus-8 seropositivity among U.S. military members recently infected with human immunodeficiency virus. Sexually Transmitted Diseases., 2003. 30(9): p. 713-8.
  4. Gonzalez, E., B.H. Rovin, L. Sen, G. Cooke, R. Dhanda, S. Mummidi, H. Kulkarni, M.J. Bamshad, V. Telles, S.A. Anderson, E.A. Walter, K.T. Stephan, M. Deucher, A. Mangano, R. Bologna, S.S. Ahuja, M.J. Dolan, and S.K. Ahuja, HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proceedings of the National Academy of Sciences of the United States of America., 2002. 99(21): p. 13795-800.
  5. Reed, J.B., J.W. Briggs, J.C. McDonald, W.R. Freeman, and L.S. Morse, Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series. Retina., 2001. 21(4): p. 339-43.
  6. Pinto, L.A., V. Blazevic, S.A. Anderson, D.J. Venzon, C.M. Trubey, T. Rowe, J.M. Katz, D. Liewehr, M.J. Dolan, and G.M. Shearer, Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects. Journal of Infectious Diseases., 2001. 183(7): p. 1000-8.
  7. Mangano, A., E. Gonzalez, R. Dhanda, G. Catano, M. Bamshad, A. Bock, R. Duggirala, K. Williams, S. Mummidi, R.A. Clark, S.S. Ahuja, M.J. Dolan, R. Bologna, L. Sen, and S.K. Ahuja, Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus. Journal of Infectious Diseases., 2001. 183(11): p. 1574-85.
  8. Grene, E., L.A. Pinto, A.L. Landay, H.A. Kessler, S.A. Anderson, M.J. Dolan, and G.M. Shearer, Anti-CCR5 antibodies in sera of HIV-positive individuals. Human Immunology., 2001. 62(2): p. 143-5.
  9. Gonzalez, E., R. Dhanda, M. Bamshad, S. Mummidi, R. Geevarghese, G. Catano, S.A. Anderson, E.A. Walter, K.T. Stephan, M.F. Hammer, A. Mangano, L. Sen, R.A. Clark, S.S. Ahuja, M.J. Dolan, and S.K. Ahuja, Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proceedings of the National Academy of Sciences of the United States of America., 2001. 98(9): p. 5199-204.
  10. Brown, A.E., M.J. Dolan, N.L. Michael, S. Zhou, S.P. Perfetto, C. Hawkes, M. Robb, J. Lane, D. Mayers, J.G. McNeil, J.D. Malone, R. Garner, D.L. Birx, and R.G.P.P.I.I.A.V.I. The, Clinical prognosis of patients with early-stage human immunodeficiency virus (HIV) disease: contribution of HIV-1 RNA and T lymphocyte subset quantitation. Military Medicine., 2001. 166(7): p. 571-6.
  11. Wegner, S.A., S.K. Brodine, J.R. Mascola, S.A. Tasker, R.A. Shaffer, M.J. Starkey, A. Barile, G.J. Martin, N. Aronson, W.W. Emmons, K. Stephan, S. Bloor, J. Vingerhoets, K. Hertogs, and B. Larder, Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel. Aids., 2000. 14(8): p. 1009-15.
  12. Walter, E.A., B. Gilliam, J.A. Delmar, K. Spooner, J.T. Morris, N. Aronson, S.A. Wegner, N.L. Michael, and L.L. Jagodzinski, Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection. Clinical Infectious Diseases., 2000. 31(3): p. 798-802.
  13. Pinto, L.A., V. Blazevic, B.K. Patterson, C. Mac Trubey, M.J. Dolan, and G.M. Shearer, Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation. Journal of Virology., 2000. 74(10): p. 4505-11.
  14. Pinto, L.A., V. Blazevic, G.M. Shearer, B.K. Patterson, and M.J. Dolan, Alloantigen-induced anti-HIV activity occurs prior to reverse transcription and can be generated by leukocytes from HIV-infected individuals.[comment]. Blood., 2000. 95(5): p. 1875-6.
  15. Pinto, L.A., M.S. Williams, M.J. Dolan, P.A. Henkart, and G.M. Shearer, Beta-chemokines inhibit activation-induced death of lymphocytes from HIV-infected individuals. European Journal of Immunology., 2000. 30(7): p. 2048-55.
  16. Mummidi, S., M. Bamshad, S.S. Ahuja, E. Gonzalez, P.M. Feuillet, K. Begum, M.C. Galvis, V. Kostecki, A.J. Valente, K.K. Murthy, L. Haro, M.J. Dolan, J.S. Allan, and S.K. Ahuja, Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus. Journal of Biological Chemistry., 2000. 275(25): p. 18946-61.
  17. More, D., K. O'Brien, and E. Walter, Utility of an HIV-1 RNA assay in the diagnosis of acute retroviral syndrome. Southern Medical Journal., 2000. 93(10): p. 1004-6.
  18. Macdonald, J.C., M.P. Karavellas, F.J. Torriani, L.S. Morse, I.L. Smith, J.B. Reed, and W.R. Freeman, Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology., 2000. 107(5): p. 877-81; discussion 881-3.
  19. Jenkins, R.A., P.R. Jenkins, E.D. Nannis, K.T. McKee, Jr., and L.R. Temoshok, Correlates of human immunodeficiency virus infection risk behavior in male attendees of a clinic for sexually transmitted disease. Clinical Infectious Diseases., 2000. 30(4): p. 723-9.
  20. Jenkins, P.R., R.A. Jenkins, E.D. Nannis, K.T. McKee, Jr., and L.R. Temoshok, Reducing risk of sexually transmitted disease (STD) and human immunodeficiency virus infection in a military STD clinic: evaluation of a randomized preventive intervention trial. Clinical Infectious Diseases., 2000. 30(4): p. 730-5.
  21. Jalali, S., J.B. Reed, M. Mizoguchi, N. Flynn, J. Gordon, and L.S. Morse, Effect of highly active antiretroviral therapy on the incidence of HIV-related cytomegalovirus retinitis and retinal detachment. AIDS Patient Care & Stds., 2000. 14(7): p. 343-6.
  22. Vahey, M., M.E. Nau, S. Barrick, J.D. Cooley, R. Sawyer, A.A. Sleeker, P. Vickerman, S. Bloor, B. Larder, N.L. Michael, and S.A. Wegner, Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms. Journal of Clinical Microbiology., 1999. 37(8): p. 2533-7.
  23. Storey, D.F., M.J. Dolan, S.A. Anderson, P.A. Meier, and E.A. Walter, Seminal plasma RANTES levels positively correlate with seminal plasma HIV-1 RNA levels. Aids., 1999. 13(15): p. 2169-71.
  24. Gonzalez, E., M. Bamshad, N. Sato, S. Mummidi, R. Dhanda, G. Catano, S. Cabrera, M. McBride, X.H. Cao, G. Merrill, P. O'Connell, D.W. Bowden, B.I. Freedman, S.A. Anderson, E.A. Walter, J.S. Evans, K.T. Stephan, R.A. Clark, S. Tyagi, S.S. Ahuja, M.J. Dolan, and S.K. Ahuja, Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proceedings of the National Academy of Sciences of the United States of America., 1999. 96(21): p. 12004-9.
  25. Wegner, S.A., P.K. Ehrenberg, G. Chang, D.E. Dayhoff, A.L. Sleeker, and N.L. Michael, Genomic organization and functional characterization of the chemokine receptor CXCR4, a major entry co-receptor for human immunodeficiency virus type 1. Journal of Biological Chemistry., 1998. 273(8): p. 4754-60.
  26. Temoshok, L.R. and R.R. Frerichs, Secondary HIV prevention. Focus: a Guide to AIDS Research., 1998. 13(7): p. 1-4.
  27. Reed, J.B. and L.S. Morse, CMV retinitis and the controversies associated with highly active antiretroviral therapy and the immune recovery hypothesis. AIDS Patient Care & Stds., 1998. 12(3): p. 181-5.
  28. Pericle, F., L.A. Pinto, S. Hicks, R.A. Kirken, G. Sconocchia, J. Rusnak, M.J. Dolan, G.M. Shearer, and D.M. Segal, HIV-1 infection induces a selective reduction in STAT5 protein expression. Journal of Immunology., 1998. 160(1): p. 28-31.
  29. Perfetto, S.P., J.D. Malone, C. Hawkes, G. McCrary, B. August, S. Zhou, R. Garner, M.J. Dolan, and A.E. Brown, CD38 expression on cryopreserved CD8+ T cells predicts HIV disease progression. Cytometry., 1998. 33(2): p. 133-7.
  30. Mummidi, S., S.S. Ahuja, E. Gonzalez, S.A. Anderson, E.N. Santiago, K.T. Stephan, F.E. Craig, P. O'Connell, V. Tryon, R.A. Clark, M.J. Dolan, and S.K. Ahuja, Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Medicine., 1998. 4(7): p. 786-93.
  31. Meier, P.A., D.P. Dooley, J.H. Jorgensen, C.C. Sanders, W.M. Huang, and J.E. Patterson, Development of quinolone-resistant Campylobacter fetus bacteremia in human immunodeficiency virus-infected patients. Journal of Infectious Diseases., 1998. 177(4): p. 951-4.
  32. Martin, M.P., M. Carrington, M. Dean, S.J. O'Brien, H.W. Sheppard, S.A. Wegner, and N.L. Michael, CXCR4 polymorphisms and HIV-1 pathogenesis. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology., 1998. 19(4): p. 430.
  33. Macdonald, J.C., F.J. Torriani, L.S. Morse, M.P. Karavellas, J.B. Reed, and W.R. Freeman, Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.[comment]. Journal of Infectious Diseases., 1998. 177(5): p. 1182-7.
  34. Hagerty, S.L. and D.P. Ascher, Spontaneous bleeding associated with the use of the protease inhibitor ritonavir in a hemophiliac patient with human immunodeficiency virus infection. Pediatric Infectious Disease Journal., 1998. 17(10): p. 929-30.
  35. Gardner, L.I., S.H. Harrison, C.W. Hendrix, S.P. Blatt, K.F. Wagner, R.C. Chung, R.W. Harris, D.L. Cohn, D.S. Burke, and D.L. Mayers, Size and duration of zidovudine benefit in 1003 HIV-infected patients: U.S. Army, Navy, and Air Force natural history data. Military Medical Consortium for Applied Retroviral Research. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology., 1998. 17(4): p. 345-53.
  36. Canzano, J.C., J.B. Reed, and L.S. Morse, Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis. Retina., 1998. 18(5): p. 443-7.
  37. Reed, J.B., I.R. Schwab, J. Gordon, and L.S. Morse, Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS.[comment]. American Journal of Ophthalmology., 1997. 124(2): p. 199-205.
  38. Lucey, D.R., L.A. Pinto, F.R. Bethke, J. Rusnak, G.P. Melcher, F.N. Hashemi, A.L. Landay, H.A. Kessler, R.J. Paxton, K. Grabstein, and G.M. Shearer, In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clinical & Diagnostic Laboratory Immunology., 1997. 4(1): p. 43-8.
  39. Le, T.P., D.R. Tribble, S.Y. Zhou, L. Malone, R.C. Chung, J.M. Rusnak, and K.F. Wagner, Clinical significance of discordant CD4 count and CD4 percentage in HIV-infected individuals. Aids., 1997. 11(11): p. 1395-6.
  40. Goetz, D.W., E.L. Webb, Jr., B.A. Whisman, and T.M. Freeman, Aeroallergen-specific IgE changes in individuals with rapid human immunodeficiency virus disease progression. Annals of Allergy, Asthma, & Immunology., 1997. 78(3): p. 301-6.
  41. Evans, J.S., T. Nims, J. Cooley, W. Bradley, L. Jagodzinski, S. Zhou, G.P. Melcher, D.S. Burke, and M. Vahey, Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in women. Journal of Infectious Diseases., 1997. 175(4): p. 795-800.
  42. Chien, S.C., A.T. Chow, M.C. Rogge, R.R. Williams, and C.W. Hendrix, Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine. Antimicrobial Agents & Chemotherapy., 1997. 41(8): p. 1765-9.
  43. Barditch-Crovo, P., J. Toole, C.W. Hendrix, K.C. Cundy, D. Ebeling, H.S. Jaffe, and P.S. Lietman, Anti-human immunodeficiency virus (HIV) activity, safety, and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients. Journal of Infectious Diseases., 1997. 176(2): p. 406-13.
  44. Ascher, D.P. and M.D. Lucy, Indinavir sulfate renal toxicity in a pediatric hemophiliac with HIV infection. Annals of Pharmacotherapy., 1997. 31(10): p. 1146-9.
  45. Wong, M.T., M.J. Dolan, E. Kozlow, R. Doe, G.P. Melcher, D.S. Burke, R.N. Boswell, and M. Vahey, Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. Journal of Infectious Diseases., 1996. 173(4): p. 877-87.
  46. Trujillo, J.R., B.A. Navia, J. Worth, D.R. Lucey, M.F. McLane, T.H. Lee, and M. Essex, High levels of anti-HIV-1 envelope antibodies in cerebrospinal fluid as compared to serum from patients with AIDS dementia complex. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology., 1996. 12(1): p. 19-25.
  47. Temoshok, L.R. and T.L. Patterson, Risk of HIV transmission in infected US military personnel.[comment]. Lancet., 1996. 347(9002): p. 697.
  48. Raszka, W.V., R.A. Moriarty, M.G. Ottolini, N.J. Waecker, D.P. Ascher, T.J. Cieslak, G.W. Fischer, and M.L. Robb, Delayed-type hypersensitivity skin testing in human immunodeficiency virus-infected pediatric patients. Journal of Pediatrics., 1996. 129(2): p. 245-50.
  49. Meier, P.A., K.T. Stephan, and S.P. Blatt, Cytomegalovirus polyradiculopathy in HIV-infected patients.[comment]. Journal of General Internal Medicine., 1996. 11(1): p. 47-9.
  50. Clerici, M., A. Sarin, J.A. Berzofsky, A.L. Landay, H.A. Kessler, F. Hashemi, C.W. Hendrix, S.P. Blatt, J. Rusnak, M.J. Dolan, R.L. Coffman, P.A. Henkart, and G.M. Shearer, Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin. Aids., 1996. 10(6): p. 603-11.
  51. Chougnet, C., T.A. Wynn, M. Clerici, A.L. Landay, H.A. Kessler, J. Rusnak, G.P. Melcher, A. Sher, and G.M. Shearer, Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. Journal of Infectious Diseases., 1996. 174(1): p. 46-53.
  52. Wong, M.T., M.J. Dolan, C.P. Lattuada, Jr., R.L. Regnery, M.L. Garcia, E.C. Mokulis, R.A. LaBarre, D.P. Ascher, J.A. Delmar, J.W. Kelly, and et al., Neuroretinitis, aseptic meningitis, and lymphadenitis associated with Bartonella (Rochalimaea) henselae infection in immunocompetent patients and patients infected with human immunodeficiency virus type 1. Clinical Infectious Diseases., 1995. 21(2): p. 352-60.
  53. Weller, P.F., W.L. Marshall, D.R. Lucey, T.H. Rand, A.M. Dvorak, and R.W. Finberg, Infection, apoptosis, and killing of mature human eosinophils by human immunodeficiency virus-1. American Journal of Respiratory Cell & Molecular Biology., 1995. 13(5): p. 610-20.
  54. Warren, R.Q., M.T. Wong, G.P. Melcher, S.P. Blatt, P. Cahn, H. Perez, I. Zapiola, M.B. Bouzas, G. Muchinik, S.A. Anderson, and et al., Serologic evaluation of human immunodeficiency virus type 1-infected individuals from Argentina and the United States indicates a similar distribution of subgroup B isolates. Journal of Clinical Microbiology., 1995. 33(2): p. 481-3.
  55. Warren, R.Q., M.T. Wong, G.P. Melcher, S.P. Blatt, I. Zapiola, M.B. Bouzas, G. Muchinik, S.A. Anderson, and R.C. Kennedy, Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression. Clinical & Diagnostic Laboratory Immunology., 1995. 2(4): p. 400-3.
  56. Shearer, G.M., D.R. Lucey, and M. Clerici, Attenuated retrovirus vaccines and AIDS.[comment]. Science., 1995. 270(5239): p. 1219; author reply 1220-2.
  57. Patterson, T.L., S.J. Semple, L.R. Temoshok, J.H. Atkinson, J.A. McCutchan, K. Straits-Troster, J.L. Chandler, and I. Grant, Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group. Psychiatry., 1995. 58(4): p. 299-312.
  58. Newton, S.M., T.M. Joys, S.A. Anderson, R.C. Kennedy, M.E. Hovi, and B.A. Stocker, Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine. Research in Microbiology., 1995. 146(3): p. 203-16.
  59. Law, W.A., R.L. Mapou, T.L. Roller, A. Martin, E.D. Nannis, and L.R. Temoshok, Reaction time slowing in HIV-1-infected individuals: role of the preparatory interval. Journal of Clinical & Experimental Neuropsychology., 1995. 17(1): p. 122-33.
  60. Jenkins, R.A., L.R. Temoshok, and K. Virochsiri, Incentives and disincentives to participate in prophylactic HIV vaccine research.[see comment]. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology., 1995. 9(1): p. 36-42.
  61. Epstein, L.J., P.J. Strollo, Jr., R.B. Donegan, J. Delmar, C. Hendrix, and P.R. Westbrook, Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep., 1995. 18(5): p. 368-76.
  62. Dolan, M.J., M. Clerici, S.P. Blatt, C.W. Hendrix, G.P. Melcher, R.N. Boswell, T.M. Freeman, W. Ward, R. Hensley, and G.M. Shearer, In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. Journal of Infectious Diseases., 1995. 172(1): p. 79-87.
  63. Cespedes, R.D., S.J. Peretsman, and S.P. Blatt, The significance of hematuria in patients infected with the human immunodeficiency virus. Journal of Urology., 1995. 154(4): p. 1455-6.
  64. Brown, A.E., J.R. Lane, K.F. Wagner, S. Zhou, R. Chung, K.L. Ray, S.P. Blatt, and D.S. Burke, Rates of p24 antigenemia and viral isolation in comparable white and black HIV-infected subjects. Military Medical Consortium for Applied Retroviral Research. Aids., 1995. 9(4): p. 325-8.
  65. Blauvelt, A., M. Clerici, D.R. Lucey, S.M. Steinberg, R. Yarchoan, R. Walker, G.M. Shearer, and S.I. Katz, Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. Journal of Immunology., 1995. 154(7): p. 3506-15.
  66. Blatt, S.P., W.F. McCarthy, B. Bucko-Krasnicka, G.P. Melcher, R.N. Boswell, J. Dolan, T.M. Freeman, J.M. Rusnak, R.E. Hensley, W.W. Ward, and et al., Multivariate models for predicting progression to AIDS and survival in human immunodeficiency virus-infected persons. Journal of Infectious Diseases., 1995. 171(4): p. 837-44.
  67. Anderson, D.W., J. DeNobile, F. Zhao, M. Vahey, J. Lane, M. Nau, A.E. Brown, S.A. Wegner, J.D. Malone, K. Wagner, and et al., Sampling lymph node content of human immunodeficiency virus type 1 nucleic acids and p24 antigen by fine-needle aspiration in early-stage patients. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology., 1995. 10(Suppl 2): p. S57-61.
  68. Temoshok, L.R., Behavioral research contributions to planning and conducting HIV vaccine efficacy studies. AIDS Research & Human Retroviruses., 1994. 10(Suppl 2): p. S277-80.
  69. Scinicariello, F., M.J. Dolan, I. Nedelcu, S.K. Tyring, and J.K. Hilliard, Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma. Virology., 1994. 203(1): p. 153-7.
  70. Sarin, A., M. Clerici, S.P. Blatt, C.W. Hendrix, G.M. Shearer, and P.A. Henkart, Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors. Journal of Immunology., 1994. 153(2): p. 862-72.
  71. Rusnak, J.M., C. Butzin, D. McGlasson, and S.P. Blatt, False-positive rapid plasma reagin tests in human immunodeficiency virus infection and relationship to anti-cardiolipin antibody and serum immunoglobulin levels.[comment]. Journal of Infectious Diseases., 1994. 169(6): p. 1356-9.
  72. Raszka, W.V., Jr., G.A. Meyer, N.J. Waecker, D.P. Ascher, R.A. Moriarty, G.W. Fischer, and M.L. Robb, Variability of serial absolute and percent CD4+ lymphocyte counts in healthy children born to human immunodeficiency virus 1-infected parents. Military Pediatric HIV Consortium. Pediatric Infectious Disease Journal., 1994. 13(1): p. 70-2.
  73. Law, W.A., A. Martin, R.L. Mapou, T.L. Roller, A.M. Salazar, L.R. Temoshok, and J.R. Rundell, Working memory in individuals with HIV infection. Journal of Clinical & Experimental Neuropsychology., 1994. 16(2): p. 173-82.
  74. Hendrix, C.W., C. Flexner, J. Szebeni, S. Kuwahara, S. Pennypacker, J.N. Weinstein, and P.S. Lietman, Effect of dipyridamole on zidovudine pharmacokinetics and short-term tolerance in asymptomatic human immunodeficiency virus-infected subjects. Antimicrobial Agents & Chemotherapy., 1994. 38(5): p. 1036-40.
  75. Clerici, M., T.A. Wynn, J.A. Berzofsky, S.P. Blatt, C.W. Hendrix, A. Sher, R.L. Coffman, and G.M. Shearer, Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. Journal of Clinical Investigation., 1994. 93(2): p. 768-75.
  76. Clerici, M., A. Sarin, R.L. Coffman, T.A. Wynn, S.P. Blatt, C.W. Hendrix, S.F. Wolf, G.M. Shearer, and P.A. Henkart, Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proceedings of the National Academy of Sciences of the United States of America., 1994. 91(25): p. 11811-5.
  77. Blatt, S.P., M.J. Dolan, C.W. Hendrix, and G.P. Melcher, Legionnaires' disease in human immunodeficiency virus-infected patients: eight cases and review.[comment]. Clinical Infectious Diseases., 1994. 18(2): p. 227-32.
  78. Wong, M.T., R.Q. Warren, S.A. Anderson, M.J. Dolan, C.W. Hendrix, S.P. Blatt, G.P. Melcher, R.N. Boswell, and R.C. Kennedy, Longitudinal analysis of the humoral immune response to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in rapidly progressing and nonprogressing HIV-1-infected subjects. Journal of Infectious Diseases., 1993. 168(6): p. 1523-7.
  79. Warner, R.D., R.E. Mathis, M.E. Weston, L.R. Bigbee, C.W. Hendrix, and D.R. Lucey, Estimates of human immunodeficiency virus (HIV) incidence and trends in the US Air Force. Vaccine., 1993. 11(5): p. 534-7.
  80. Waecker, N.J., Jr., D.P. Ascher, M.L. Robb, R. Moriarty, M. Krober, W.J. Rickman, C.A. Butzin, and G.W. Fischer, Age-adjusted CD4+ lymphocyte parameters in healthy children at risk for infection with the human immunodeficiency virus. The Military Pediatric HIV Consortium. Clinical Infectious Diseases., 1993. 17(1): p. 123-5.
  81. Sylwester, A., D. Wessels, S.A. Anderson, R.Q. Warren, D.C. Shutt, R.C. Kennedy, and D.R. Soll, HIV-induced syncytia of a T cell line form single giant pseudopods and are motile. Journal of Cell Science., 1993. 106(Pt 3): p. 941-53.
  82. Semple, S.J., T.L. Patterson, L.R. Temoshok, J.A. McCutchan, K.A. Straits-Troster, J.L. Chandler, and I. Grant, Identification of psychobiological stressors among HIV-positive women. HIV Neurobehavioral Research Center (HNRC) Group. Women & Health., 1993. 20(4): p. 15-36.
  83. Schulick, R.D., M. Clerici, M.J. Dolan, and G.M. Shearer, Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals. European Journal of Immunology., 1993. 23(2): p. 412-7.
  84. McManis, S.E., G.R. Brown, R. Zachary, and J.R. Rundell, A screening test for subtle cognitive impairment early in the course of HIV infection. Psychosomatics., 1993. 34(5): p. 424-31.
  85. Mapou, R.L., W.A. Law, A. Martin, D. Kampen, A.M. Salazar, and J.R. Rundell, Neuropsychological performance, mood, and complaints of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus. Journal of Neuropsychiatry & Clinical Neurosciences., 1993. 5(1): p. 86-93.
  86. Mapou, R.L., G.G. Kay, J.R. Rundell, and L. Temoshok, Measuring performance decrements in aviation personnel infected with the human immunodeficiency virus. Aviation Space & Environmental Medicine., 1993. 64(2): p. 158-64.
  87. Mapou, R.L., J.R. Rundell, G.G. Kay, and E.C. Tramont, Relating cognitive function to military aviator performance in early HIV infection. Vaccine., 1993. 11(5): p. 555-9.
  88. Lucey, D.R., T.C. VanCott, L.D. Loomis, F.R. Bethke, C.W. Hendrix, G.P. Melcher, R.R. Redfield, and D.L. Birx, Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop). Journal of Acquired Immune Deficiency Syndromes., 1993. 6(9): p. 994-1001.
  89. Lucey, D.R., S.A. McGuire, S. Abbadessa, K. Hall, B. Woolford, S. Valtier, C.A. Butzin, G.P. Melcher, and C.W. Hendrix, Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune status. Viral Immunology., 1993. 6(4): p. 267-72.
  90. Lucey, D.R., W.F. McCarthy, S.P. Blatt, G.P. Melcher, and C.W. Hendrix, Racial differences in serum beta 2-microglobulin in persons with human immunodeficiency virus infection. Journal of Infectious Diseases., 1993. 167(5): p. 1259-60.
  91. Ferrante, M.A. and M.J. Dolan, Q fever meningoencephalitis in a soldier returning from the Persian Gulf War. Clinical Infectious Diseases., 1993. 16(4): p. 489-96.
  92. Dolan, M.J., D.R. Lucey, C.W. Hendrix, G.P. Melcher, G.A. Spencer, and R.N. Boswell, Early markers of HIV infection and subclinical disease progression. Vaccine., 1993. 11(5): p. 548-51.
  93. Clerici, M., F.T. Hakim, D.J. Venzon, S. Blatt, C.W. Hendrix, T.A. Wynn, and G.M. Shearer, Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. Journal of Clinical Investigation., 1993. 91(3): p. 759-65.
  94. Clerici, M., R. Yarchoan, S. Blatt, C.W. Hendrix, A.J. Ammann, S. Broder, and G.M. Shearer, Effect of a recombinant CD4-IgG on in vitro T helper cell function: data from a phase I/II study of patients with AIDS. Journal of Infectious Diseases., 1993. 168(4): p. 1012-6.
  95. Clerici, M., D.R. Lucey, J.A. Berzofsky, L.A. Pinto, T.A. Wynn, S.P. Blatt, M.J. Dolan, C.W. Hendrix, S.F. Wolf, and G.M. Shearer, Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science., 1993. 262(5140): p. 1721-4.
  96. Brown, G.R., J.R. Rundell, S.E. McManis, S.N. Kendall, and R.A. Jenkins, Neuropsychiatric morbidity in early HIV disease: implications for military occupational function. Vaccine., 1993. 11(5): p. 560-9.
  97. Brown, G.R. and J.R. Rundell, A prospective study of psychiatric aspects of early HIV disease in women. General Hospital Psychiatry., 1993. 15(3): p. 139-47.
  98. Blatt, S.P., C.R. Lucey, C.A. Butzin, C.W. Hendrix, and D.R. Lucey, Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. Jama., 1993. 269(5): p. 622-6.
  99. Blatt, S.P., C.W. Hendrix, C.A. Butzin, T.M. Freeman, W.W. Ward, R.E. Hensley, G.P. Melcher, D.J. Donovan, and R.N. Boswell, Delayed-type hypersensitivity skin testing predicts progression to AIDS in HIV-infected patients.[comment]. Annals of Internal Medicine., 1993. 119(3): p. 177-84.
  100. Barohn, R.J., G.S. Gronseth, B.R. LeForce, A.L. McVey, S.A. McGuire, C.A. Butzin, and R.B. King, Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals.[erratum appears in Arch Neurol 1993 Apr;50(4):388]. Archives of Neurology., 1993. 50(2): p. 167-71.
  101. Ascher, D.P. and C. Roberts, Determination of the etiology of seroreversals in HIV testing by antibody fingerprinting. Journal of Acquired Immune Deficiency Syndromes., 1993. 6(3): p. 241-4.
  102. Warren, R.Q., W.M. Nkya, J.F. Shao, S.A. Anderson, H. Wolf, C.W. Hendrix, P. Kanda, M. Wabuke, R.N. Boswell, R.R. Redfield, and et al., Comparison of antibody reactivity to human immunodeficiency virus type 1 (HIV-1) gp160 epitopes in sera from HIV-1-infected individuals from Tanzania and from the United States. Journal of Clinical Microbiology., 1992. 30(1): p. 126-31.
  103. Warren, R.Q., S.A. Anderson, W.M. Nkya, J.F. Shao, C.W. Hendrix, G.P. Melcher, R.R. Redfield, and R.C. Kennedy, Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activity. Journal of Virology., 1992. 66(9): p. 5210-5.
  104. Rundell, J.R., K.M. Kyle, G.R. Brown, and J.L. Thomason, Risk factors for suicide attempts in a human immunodeficiency virus screening program. Psychosomatics., 1992. 33(1): p. 24-7.
  105. Nkya, W.M., R.Q. Warren, H. Wolf, C.W. Hendrix, J. Tesha, R.R. Redfield, G.P. Melcher, D.S. Burke, P. Kanda, and R.C. Kennedy, Fine specificity of the humoral immune response to HIV-1 GP160 in HIV-1 infected individuals from Tanzania. Journal of Medical Virology., 1992. 37(1): p. 61-6.
  106. Nixon, A., H. Zaghouani, C.L. Penney, M. Lacroix, G. Dionne, S.A. Anderson, R.C. Kennedy, and C.A. Bona, Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160. Viral Immunology., 1992. 5(2): p. 141-50.
  107. Lucey, D.R., C.W. Hendrix, C. Andrzejewski, G.P. Melcher, C.A. Butzin, R. Henry, F.H. Wians, Jr., and R.N. Boswell, Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. Journal of Acquired Immune Deficiency Syndromes., 1992. 5(4): p. 325-32.
  108. Clerici, M., A.L. Landay, H.A. Kessler, J.P. Phair, D.J. Venzon, C.W. Hendrix, D.R. Lucey, and G.M. Shearer, Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients. Journal of Infectious Diseases., 1992. 166(4): p. 723-30.
  109. Brown, G.R., J.R. Rundell, S.E. McManis, S.N. Kendall, R. Zachary, and L. Temoshok, Prevalence of psychiatric disorders in early stages of HIV infection. Psychosomatic Medicine., 1992. 54(5): p. 588-601.
  110. Blay, R., D. Hernandez, M. Betts, M. Clerici, D.R. Lucey, C. Hendrix, T. Hoffman, and B. Golding, Brucella abortus stimulates human T cells from uninfected and HIV-infected individuals to secrete IFN gamma: implications for use of Brucella abortus as a carrier in development of human vaccines. AIDS Research & Human Retroviruses., 1992. 8(4): p. 479-86.
  111. Ascher, D.P., C. Roberts, and A. Fowler, Acidification modified p24 antigen capture assay in HIV seropositives. Journal of Acquired Immune Deficiency Syndromes., 1992. 5(11): p. 1080-3.
  112. Warren, R.Q., H. Wolf, R.A. Zajac, R.N. Boswell, P. Kanda, and R.C. Kennedy, Patterns of antibody reactivity to selected human immunodeficiency virus type 1 (HIV-1) gp160 epitopes infected individuals grouped according to CD4+ cell levels. Journal of Clinical Immunology., 1991. 11(1): p. 13-21.
  113. Marshall, D.W., R.L. Brey, C.A. Butzin, D.R. Lucey, S.M. Abbadessa, and R.N. Boswell, CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel. Journal of Acquired Immune Deficiency Syndromes., 1991. 4(8): p. 777-81.
  114. Lucey, D.R., The first decade of human retroviruses: a nomenclature for the clinician. Military Medicine., 1991. 156(10): p. 555-7.
  115. Lucey, D.R., R.E. Hensley, W.W. Ward, C.A. Butzin, and R.N. Boswell, CD4+ monocyte counts in persons with HIV-1 infection: an early increase is followed by a progressive decline. Journal of Acquired Immune Deficiency Syndromes., 1991. 4(1): p. 24-30.
  116. Lucey, D.R., S.A. McGuire, M. Clerici, K. Hall, J. Benton, C.A. Butzin, W.W. Ward, G. Shearer, R.N. Boswell, and C.W. Hendrix, Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1. Journal of Infectious Diseases., 1991. 163(5): p. 971-5.
  117. Lucey, D.R., M. Nunley, R.N. Boswell, T.L. Koopman, R.E. Hensley, and W.W. Ward, HLA-DR+ CD8+ T cells in the cerebrospinal fluid of a patient with AIDS dementia complex and 355-494/mm3 CD4+ peripheral blood T cells. Journal of Acquired Immune Deficiency Syndromes., 1991. 4(6): p. 638-9.
  118. Lucey, D.R., G.P. Melcher, C.W. Hendrix, R.A. Zajac, D.W. Goetz, C.A. Butzin, M. Clerici, R.D. Warner, S. Abbadessa, K. Hall, and et al., Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts. Journal of Infectious Diseases., 1991. 164(4): p. 631-7.
  119. LaRosa, G.J., J.P. Davide, K. Weinhold, J.A. Waterbury, A.T. Profy, J.A. Lewis, A.J. Langlois, G.R. Dreesman, R.N. Boswell, P. Shadduck, and et al., Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications. Science., 1991. 251(4995): p. 811.
  120. LaRosa, G.J., K. Weinhold, A.T. Profy, A.J. Langlois, G.R. Dreesman, R.N. Boswell, P. Shadduck, D.P. Bolognesi, T.J. Matthews, E.A. Emini, and et al., Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: further clarifications. Science., 1991. 253(5024): p. 1146.
  121. Horowitz, G.M., R.T. Scott, and G.D. Hankins, Results of a prenatal screening program for the human immunodeficiency virus in a cross-sectional population. Journal of Reproductive Medicine., 1991. 36(11): p. 773-8.
  122. Hendrix, C.W., P.A. Volberding, and R.E. Chaisson, HIV antigen variability in ARC/AIDS. Journal of Acquired Immune Deficiency Syndromes., 1991. 4(9): p. 847-50.
  123. Fuchs, D., G.M. Shearer, R.N. Boswell, D.R. Lucey, M. Clerici, G. Reibnegger, E.R. Werner, R.A. Zajac, and H. Wachter, Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. Aids., 1991. 5(2): p. 209-12.
  124. Flexner, C., P.A. Barditch-Crovo, D.M. Kornhauser, H. Farzadegan, L.J. Nerhood, R.E. Chaisson, K.M. Bell, K.J. Lorentsen, C.W. Hendrix, B.G. Petty, and et al., Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrobial Agents & Chemotherapy., 1991. 35(12): p. 2544-50.
  125. De Groot, A.S., M. Clerici, A. Hosmalin, S.H. Hughes, D. Barnd, C.W. Hendrix, R. Houghten, G.M. Shearer, and J.A. Berzofsky, Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. Journal of Infectious Diseases., 1991. 164(6): p. 1058-65.
  126. Davis, C., HIV-specific treatment. Dermatologic Clinics., 1991. 9(3): p. 585-96.
  127. Clerici, M., A.L. Landay, H.A. Kessler, R.A. Zajac, R.N. Boswell, S.C. Muluk, and G.M. Shearer, Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. Journal of Immunology., 1991. 146(7): p. 2207-13.
  128. Clerici, M., D.R. Lucey, R.A. Zajac, R.N. Boswell, H.M. Gebel, H. Takahashi, J.A. Berzofsky, and G.M. Shearer, Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. Journal of Immunology., 1991. 146(7): p. 2214-9.
  129. Clerici, M., C.S. Via, D.R. Lucey, E. Roilides, P.A. Pizzo, and G.M. Shearer, Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection. European Journal of Immunology., 1991. 21(3): p. 665-70.
  130. Clerici, M., C.O. Tacket, C.S. Via, D.R. Lucey, S.C. Muluk, R.A. Zajac, R.N. Boswell, J.A. Berzofsky, and G.M. Shearer, Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection. European Journal of Immunology., 1991. 21(6): p. 1345-9.
  131. Brey, R.L., R. Arroyo, and R.N. Boswell, Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes., 1991. 4(4): p. 435-41.
  132. Blatt, S.P., D.R. Lucey, D. DeHoff, and R.B. Zellmer, Rhinocerebral zygomycosis in a patient with AIDS. Journal of Infectious Diseases., 1991. 164(1): p. 215-6.
  133. Blackburn, R., M. Clerici, D. Mann, D.R. Lucey, J. Goedert, B. Golding, G.M. Shearer, and H. Golding, Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection. Advances in Experimental Medicine & Biology., 1991. 303: p. 63-9.
  134. Berzofsky, J.A., C.D. Pendleton, M. Clerici, J. Ahlers, D.R. Lucey, S.D. Putney, and G.M. Shearer, Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types. Journal of Clinical Investigation., 1991. 88(3): p. 876-84.
  135. Berzofsky, J.A., C.D. Pendleton, M. Clerici, J. Ahlers, D.R. Lucey, S.D. Putney, and G.M. Shearer, Peptides containing multideterminant clusters of human immunodeficiency virus envelope induce murine and human T-cell responses in diverse histocompatibility types. Transactions of the Association of American Physicians., 1991. 104: p. 69-77.
  136. Warren, R.Q., H. Wolf, K.R. Shuler, J.W. Eichberg, R.A. Zajac, R.N. Boswell, P. Kanda, and R.C. Kennedy, Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees. Journal of Virology., 1990. 64(2): p. 486-92.
  137. Rundell, J.R. and G.R. Brown, Persistence of psychiatric symptoms in HIV seropositive persons. American Journal of Psychiatry., 1990. 147(5): p. 674-5.
  138. Praus, D.J., J.L. Thomason, and J.R. Rundell, Lack of association between CSF findings and request for psychiatric evaluation of HIV-infected patients. Psychosomatics., 1990. 31(1): p. 116-8.
  139. Praus, D.J., G.R. Brown, J.R. Rundell, and S.L. Paolucci, Associations between cerebrospinal fluid parameters and high degrees of anxiety or depression in United States Air Force personnel infected with human immunodeficiency virus. Journal of Nervous & Mental Disease., 1990. 178(6): p. 392-5.
  140. Pace, J., G.R. Brown, J.R. Rundell, S. Paolucci, K. Drexler, and S. McManis, Prevalence of psychiatric disorders in a mandatory screening program for infection with human immunodeficiency virus: a pilot study. Military Medicine., 1990. 155(2): p. 76-80.
  141. Lucey, D., S. Milum, C. Lindquist, C. Andrzejewski, J. Benton, and R.N. Boswell, Pseudofailure of zidovudine prophylaxis after a human immunodeficiency virus-positive needlestick. Journal of Infectious Diseases., 1990. 162(5): p. 1211-2.
  142. Lucey, D.R., R.A. Zajac, G.P. Melcher, C.A. Butzin, and R.N. Boswell, Serum IgE levels in 622 persons with human immunodeficiency virus infection: IgE elevation with marked depletion of CD4+ T-cells. AIDS Research & Human Retroviruses., 1990. 6(4): p. 427-9.
  143. Lucey, D.R. and C.R. Lucey, Infectious disease emergencies in persons with HIV/AIDS: an update. Journal of the Arkansas Medical Society., 1990. 87(4): p. 156-61.
  144. Lucey, D.R., C.W. Hendrix, C. Andrzejewski, D. McGlasson, W.W. Ward, G.P. Melcher, R.A. Zajac, and R.N. Boswell, Hepatitis C antibody in a non-hemophiliac cohort infected with the human immunodeficiency virus. Viral Immunology., 1990. 3(4): p. 295-301.
  145. LaRosa, G.J., J.P. Davide, K. Weinhold, J.A. Waterbury, A.T. Profy, J.A. Lewis, A.J. Langlois, G.R. Dreesman, R.N. Boswell, P. Shadduck, and et al., Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.[erratum appears in Science 1991 Feb 15;251(4995):811]. Science., 1990. 249(4971): p. 932-5.
  146. Fuchs, D., G.M. Shearer, R.N. Boswell, M. Clerici, G. Reibnegger, E.R. Werner, R.A. Zajac, and H. Wachter, Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clinical & Experimental Immunology., 1990. 80(1): p. 44-8.
  147. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, and G.M. Shearer, Accessory cell function in asymptomatic human immunodeficiency virus-infected patients. Clinical Immunology & Immunopathology., 1990. 54(2): p. 168-73.
  148. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, C.S. Via, and G.M. Shearer, Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens. Journal of Immunology., 1990. 144(9): p. 3266-71.
  149. Brown, G.R. and J.R. Rundell, Prospective study of psychiatric morbidity in HIV-seropositive women without AIDS. General Hospital Psychiatry., 1990. 12(1): p. 30-5.
  150. Beck, D.E., R.G. Jaso, and R.A. Zajac, Surgical management of anal condylomata in the HIV-positive patient. Diseases of the Colon & Rectum., 1990. 33(3): p. 180-3.
  151. Beck, D.E., R.G. Jaso, and R.A. Zajac, Proctologic management of the HIV-positive patient. Southern Medical Journal., 1990. 83(8): p. 900-3.
  152. Rundell, J.R., F.E. Hebert, and G.R. Brown, Use of home test kits for HIV is bad medicine. Jama., 1989. 262(17): p. 2385-6.
  153. Ridley, D.J., R.W. Houk, M.J. Reid, and R.N. Boswell, Early lymphocyte transformation abnormalities in human immunodeficiency virus infection. Journal of Clinical Immunology., 1989. 9(2): p. 119-24.
  154. Melcher, G.P., AIDS in Arkansas. The immunopathogenesis of human immunodeficiency virus. Journal of the Arkansas Medical Society., 1989. 85(11): p. 479-83.
  155. Marshall, D.W., R.L. Brey, and C.A. Butzin, Lack of cerebrospinal fluid myelin basic protein in HIV-infected asymptomatic individuals with intrathecal synthesis of IgG.[comment]. Neurology., 1989. 39(8): p. 1127-9.
  156. Lucey, D.R., D.I. Dorsky, A. Nicholson-Weller, and P.F. Weller, Human eosinophils express CD4 protein and bind human immunodeficiency virus 1 gp120. Journal of Experimental Medicine., 1989. 169(1): p. 327-32.
  157. Golding, H., G.M. Shearer, K. Hillman, P. Lucas, J. Manischewitz, R.A. Zajac, M. Clerici, R.E. Gress, R.N. Boswell, and B. Golding, Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. Journal of Clinical Investigation., 1989. 83(4): p. 1430-5.
  158. Goethe, K.E., J.E. Mitchell, D.W. Marshall, R.L. Brey, W.T. Cahill, G.D. Leger, L.J. Hoy, and R.N. Boswell, Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals. Archives of Neurology., 1989. 46(2): p. 129-33.
  159. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, D.C. Bernstein, D.L. Mann, G.M. Shearer, and J.A. Berzofsky, Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature., 1989. 339(6223): p. 383-5.
  160. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, and G.M. Shearer, Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. Journal of Clinical Investigation., 1989. 84(6): p. 1892-9.
  161. Brown, G.R. and J. Pace, Reduced sexual activity in HIV-infected homosexual men. Jama., 1989. 261(17): p. 2503-4.
  162. Brown, G.R. and J.R. Rundell, Suicidal tendencies in women with human immunodeficiency virus infection.[erratum appears in Am J Psychiatry 1989 Jun;146(6):818]. American Journal of Psychiatry., 1989. 146(4): p. 556-7.
  163. Rundell, J.R., S.L. Paolucci, D.C. Beatty, and R.N. Boswell, Psychiatric illness at all stages of human immunodeficiency virus infection. American Journal of Psychiatry., 1988. 145(5): p. 652-3.
  164. Reid, M.J., D.W. Goetz, R.A. Zajac, R.W. Houk, and R.N. Boswell, The natural history of human immunodeficiency virus infection in screened HIV positive U.S. Air Force personnel: a preliminary report. Journal of Acquired Immune Deficiency Syndromes., 1988. 1(5): p. 508-15.
  165. Marshall, D.W., HIV penetration of the BBB. Neurology., 1988. 38(6): p. 1000-1.
  166. Marshall, D.W., R.L. Brey, W.T. Cahill, R.W. Houk, R.A. Zajac, and R.N. Boswell, Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Archives of Neurology., 1988. 45(9): p. 954-8.
  167. Goetz, D.W., S.E. Hall, R.W. Harbison, and M.J. Reid, Pediatric acquired immunodeficiency syndrome with negative human immunodeficiency virus antibody response by enzyme-linked immunosorbent assay and Western blot. Pediatrics., 1988. 81(3): p. 356-9.
  168. Fling, J.A., J.R. Fischer, Jr., R.N. Boswell, and M.J. Reid, The relationship of serum IgA concentration to human immunodeficiency virus (HIV) infection: a cross-sectional study of HIV-seropositive individuals detected by screening in the United States Air Force. Journal of Allergy & Clinical Immunology., 1988. 82(6): p. 965-70.
  169. Boswell, R.N., AIDS in Arkansas. AIDS 1988. Journal of the Arkansas Medical Society., 1988. 85(2): p. 73-85.
  170. Berger, R.S., M.F. Stoner, E.R. Hobbs, T.J. Hayes, and R.N. Boswell, Cutaneous manifestations of early human immunodeficiency virus exposure. Journal of the American Academy of Dermatology., 1988. 19(2 Pt 1): p. 298-303.
  171. Appleman, M.E., D.W. Marshall, R.L. Brey, R.W. Houk, D.C. Beatty, R.E. Winn, G.P. Melcher, M.G. Wise, C.V. Sumaya, and R.N. Boswell, Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. Journal of Infectious Diseases., 1988. 158(1): p. 193-9.
  172. Alsip, G.R., Y. Ench, C.V. Sumaya, and R.N. Boswell, Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. Journal of Infectious Diseases., 1988. 157(5): p. 1072-6.
  173. Kennedy, R.C., G.R. Dreesman, T.C. Chanh, R.N. Boswell, J.S. Allan, T.H. Lee, M. Essex, J.T. Sparrow, D.D. Ho, and P. Kanda, Use of a resin-bound synthetic peptide for identifying a neutralizing antigenic determinant associated with the human immunodeficiency virus envelope. Journal of Biological Chemistry., 1987. 262(12): p. 5769-74.
  174. Sumaya, C.V., R.N. Boswell, Y. Ench, D.L. Kisner, E.M. Hersh, J.M. Reuben, and P.W. Mansell, Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS-related complex. Journal of Infectious Diseases., 1986. 154(5): p. 864-70.
  175. Rundell, J.R., M.G. Wise, and R.J. Ursano, Three cases of AIDS-related psychiatric disorders. American Journal of Psychiatry., 1986. 143(6): p. 777-8.
  176. South, M.A., J. Dolen, D.K. Beach, and R.R. Mirkovic, Fatal adenovirus hepatic necrosis in severe combined immune deficiency. Pediatric Infectious Disease., 1982. 1(6): p. 416-9.
  177. Pabst, H.F., G.S. Chung, D. Segal, and J. Dolen, Mild combined immunodeficiency in identical twins. Journal of Pediatrics., 1976. 89(3): p. 425-8.